Teladoc Health, Inc. (NYSE:TDOC) Position Lessened by Vontobel Holding Ltd.

Vontobel Holding Ltd. trimmed its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 9.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,270 shares of the health services provider’s stock after selling 1,345 shares during the period. Vontobel Holding Ltd.’s holdings in Teladoc Health were worth $121,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of TDOC. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Teladoc Health by 15.5% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after buying an additional 228,004 shares in the last quarter. Jennison Associates LLC bought a new position in Teladoc Health during the third quarter valued at about $1,544,000. Massachusetts Financial Services Co. MA grew its position in shares of Teladoc Health by 477.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock valued at $3,397,000 after purchasing an additional 305,961 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. acquired a new stake in shares of Teladoc Health in the third quarter valued at about $11,291,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

TDOC has been the topic of several research analyst reports. Royal Bank of Canada raised their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. The Goldman Sachs Group raised their price target on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. TD Cowen lowered their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Finally, Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Thirteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $11.81.

Insider Activity

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.95% of the stock is currently owned by corporate insiders.

Teladoc Health Stock Performance

NYSE:TDOC opened at $11.52 on Friday. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $15.95. The firm has a 50 day moving average of $10.55 and a 200-day moving average of $9.44. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.98 billion, a P/E ratio of -2.00 and a beta of 1.05.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.